Therapeutic treatment of rheumatoid arthritis and polymyalgia rheumatica
AssigneeResearch Corporation Technologies, Inc.
InventorRobert M. Bennett
Life of this patent
Estimating the term…
Abstract
Disclosed is a therapeutic regime for treating patients with rheumatoid arthritis (RA) Supplemental growth hormone is periodically administered to raise insulin-like growth factor 1 (IGF-1) levels, and the IGF-1 levels are monitored until they reach optimal levels and RA symptoms subside.
Claims14
A method for treatment of adult rheumatoid arthritis in a human patient comprising administering to said patient a pharmaceutically effective amount of human growth hormone.
A method for treatment of polymyalgia rheumatica in a human patent comprising administering to said patient a pharmaceutically effective amount of human growth hormone.
Dependencies are inferred from the claim text.